Healthcare analyst Iain Wilkie runs through some market news, a number of updates for stocks under coverage, and some comments on the relaxation of a number of elective medical procedures announced over the week.

Under the microscope: Resmed (ASX:RMD) - Derek Jellinek, Senior Analyst

A series of podcasts that include interviews with executives from ASX-listed companies and updates on the healthcare sector.